Mark Bunker

1.8k total citations
32 papers, 1.2k citations indexed

About

Mark Bunker is a scholar working on Neurology, Psychiatry and Mental health and Neurology. According to data from OpenAlex, Mark Bunker has authored 32 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Neurology, 13 papers in Psychiatry and Mental health and 12 papers in Neurology. Recurrent topics in Mark Bunker's work include Vagus Nerve Stimulation Research (20 papers), Treatment of Major Depression (10 papers) and Neurological disorders and treatments (10 papers). Mark Bunker is often cited by papers focused on Vagus Nerve Stimulation Research (20 papers), Treatment of Major Depression (10 papers) and Neurological disorders and treatments (10 papers). Mark Bunker collaborates with scholars based in United States, Singapore and United Kingdom. Mark Bunker's co-authors include Charles R. Conway, Scott T. Aaronson, Bryan Olin, Frederick W. Reimherr, Thomas L. Schwartz, Darin D. Dougherty, John Zajecka, A. John Rush, Francisco Moreno and Arun Kumar and has published in prestigious journals such as PLoS ONE, American Journal of Psychiatry and Biological Psychiatry.

In The Last Decade

Mark Bunker

27 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Bunker United States	15	765	479	429	383	202	32	1.2k
Barry R. Rittberg United States	8	826 1.1×	257 0.5×	489 1.1×	293 0.8×	281 1.4×	14	1.2k
Pilar Cristancho United States	17	404 0.5×	293 0.6×	123 0.3×	252 0.7×	247 1.2×	33	962
Jiliang Fang China	16	662 0.9×	187 0.4×	213 0.5×	578 1.5×	85 0.4×	50	1.3k
Jiliang Fang China	18	445 0.6×	292 0.6×	135 0.3×	463 1.2×	95 0.5×	50	1.3k
Katharina M. Hösl Germany	14	506 0.7×	157 0.3×	177 0.4×	328 0.9×	77 0.4×	22	1.3k
Anthony de Castella Australia	19	806 1.1×	689 1.4×	143 0.3×	499 1.3×	122 0.6×	42	1.8k
E. Ben‐Menachem Sweden	9	713 0.9×	384 0.8×	447 1.0×	515 1.3×	25 0.1×	11	1.3k
Andrew M. Youssef United States	15	172 0.2×	211 0.4×	114 0.3×	299 0.8×	305 1.5×	21	1.0k
Ciarán Corcoran Ireland	8	327 0.4×	326 0.7×	179 0.4×	173 0.5×	95 0.5×	17	790
Mandana Modirrousta Canada	17	429 0.6×	357 0.7×	128 0.3×	706 1.8×	157 0.8×	31	1.3k

Countries citing papers authored by Mark Bunker

Since Specialization

Citations

This map shows the geographic impact of Mark Bunker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Bunker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Bunker more than expected).

Fields of papers citing papers by Mark Bunker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Bunker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Bunker. The network helps show where Mark Bunker may publish in the future.

Co-authorship network of co-authors of Mark Bunker

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Bunker. A scholar is included among the top collaborators of Mark Bunker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Bunker. Mark Bunker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Conway, Charles R., Charles M. Gordon, Sheldon Preskorn, et al.. (2025). An examination of symptoms, function and quality of life as conjoint clinical outcome domains for treatment-resistant depression. PubMed. 10. 100121–100121.

Aaronson, Scott T., Charles R. Conway, Charles M. Gordon, et al.. (2025). Prognostic and Prescriptive Predictors of Treatment Response to Adjunctive VNS Therapy in Major Depressive Disorder. The Journal of Clinical Psychiatry. 86(3).

Sackeïm, Harold A., Charles R. Conway, Scott T. Aaronson, et al.. (2025). Characterizing the effects of vagus nerve stimulation on symptom improvement in markedly treatment-resistant major depressive disorder: A RECOVER trial report. Journal of Affective Disorders. 380. 135–145.

Sackeïm, Harold A., Scott T. Aaronson, Mark Bunker, et al.. (2024). Update on the assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form-2 (ATHF-SF2). Journal of Psychiatric Research. 176. 325–337. 4 indexed citations

Aaronson, Scott T., Harold A. Sackeïm, Teresa Greco, et al.. (2023). Alternative metrics for characterizing longer-term clinical outcomes in difficult-to-treat depression: II. Sensitivity to treatment effects. Australian & New Zealand Journal of Psychiatry. 58(3). 250–259. 5 indexed citations

Sackeïm, Harold A., A. John Rush, Teresa Greco, et al.. (2023). Alternative metrics for characterizing longer-term clinical outcomes in difficult-to-treat depression: I. Association with change in quality of life. Psychological Medicine. 53(14). 6511–6523. 4 indexed citations

Sackeïm, Harold A., Maxine Dibué, Mark Bunker, & A. John Rush. (2020). <p>The Long and Winding Road of Vagus Nerve Stimulation: Challenges in Developing an Intervention for Difficult-to-Treat Mood Disorders</p>. Neuropsychiatric Disease and Treatment. Volume 16. 3081–3093. 9 indexed citations

McAllister‐Williams, R. Hamish, Arun Kumar, Teresa Greco, et al.. (2020). The effects of vagus nerve stimulation on the course and outcomes of patients with bipolar disorder in a treatment-resistant depressive episode: a 5-year prospective registry. International Journal of Bipolar Disorders. 8(1). 13–13. 21 indexed citations

Conway, Charles R., Bryan Olin, Scott T. Aaronson, et al.. (2020). A prospective, multi-center randomized, controlled, blinded trial of vagus nerve stimulation for difficult to treat depression: A novel design for a novel treatment. Contemporary Clinical Trials. 95. 106066–106066. 17 indexed citations

10.

Sackeïm, Harold A., Scott T. Aaronson, Mark Bunker, et al.. (2019). The assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form (ATHF-SF). Journal of Psychiatric Research. 113. 125–136. 69 indexed citations

11.

Kumar, Arun, Mark Bunker, Scott T. Aaronson, et al.. (2019). <p>Durability of symptomatic responses obtained with adjunctive vagus nerve stimulation in treatment-resistant depression</p>. Neuropsychiatric Disease and Treatment. Volume 15. 457–468. 28 indexed citations

12.

Conway, Charles R., Arun Kumar, Willa Xiong, et al.. (2018). Chronic Vagus Nerve Stimulation Significantly Improves Quality of Life in Treatment-Resistant Major Depression. The Journal of Clinical Psychiatry. 79(5). 62 indexed citations

13.

Aaronson, Scott T., Mark Bunker, Charles R. Conway, et al.. (2017). A 5-Year Observational Study of Patients With Treatment-Resistant Depression Treated With Vagus Nerve Stimulation or Treatment as Usual: Comparison of Response, Remission, and Suicidality. American Journal of Psychiatry. 174(7). 640–648. 234 indexed citations

14.

Burke, Tom, et al.. (2015). A study of the impact of VNS on health care utilisation in England. Seizure. 34. 12–17. 5 indexed citations

15.

Camp, Charlotte, W. Henry Smithson, Mark Bunker, Tom Burke, & David Hughes. (2015). Impact of vagus nerve stimulation on secondary care burden in children and adults with epilepsy: Review of routinely collected hospital data in England. Epilepsy & Behavior. 52(Pt A). 68–73. 13 indexed citations

16.

Olin, Bryan, et al.. (2012). Mortality and Suicide Risk in Treatment-Resistant Depression: An Observational Study of the Long-Term Impact of Intervention. PLoS ONE. 7(10). e48002–e48002. 51 indexed citations

17.

Aaronson, Scott T., Linda L. Carpenter, Charles R. Conway, et al.. (2012). Vagus Nerve Stimulation Therapy Randomized to Different Amounts of Electrical Charge for Treatment-Resistant Depression: Acute and Chronic Effects. Brain stimulation. 6(4). 631–640. 126 indexed citations

18.

Helmers, Sandra L., Mei Sheng Duh, Annie Guérin, et al.. (2012). Clinical outcomes, quality of life, and costs associated with implantation of vagus nerve stimulation therapy in pediatric patients with drug-resistant epilepsy. European Journal of Paediatric Neurology. 16(5). 449–458. 66 indexed citations

19.

Duh, Mei Sheng, Edward Faught, A. Guérin, et al.. (2011). PMD1 IMPACT OF VAGUS NERVE STIMULATION (VNS) THERAPY ON CLINICAL OUTCOMES AND COSTS IN MEDICAID PATIENTS WITH DRUG-RESISTANT EPILEPSY. Value in Health. 14(3). A79–A79. 1 indexed citations

20.

Helmers, Sandra L., Mei Sheng Duh, Annie Guérin, et al.. (2011). Clinical and economic impact of vagus nerve stimulation therapy in patients with drug-resistant epilepsy. Epilepsy & Behavior. 22(2). 370–375. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact